Literature DB >> 17645777

Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins.

Mako Narisawa-Saito1, Tohru Kiyono.   

Abstract

Human papillomaviruses (HPV) are believed to be the primary causal agents for development of pre-neoplastic and malignant lesions of the uterine cervix, and high-risk types such as type 16 and 18 are associated with more than 90% of all cervical carcinomas. The E6 and E7 genes of HPV are thought to play causative roles, since E6 promotes the degradation of p53 through its interaction with E6AP, an E3 ubiquitin ligase, whereas E7 binds to the retinoblastoma protein (pRb) and disrupts its complex formation with E2F transcription factors. Although prophylactic vaccines have become available, it is still necessary to clarify the mechanisms of HPV-induced carcinogenesis because of the widespread nature of HPV infection. Approximately 493,000 new cases of cervical cancer are diagnosed each year with approximately 274,000 mortalities due to invasive cervical cancer. In the present article, the mechanisms of HPV16 E6- and E7-induced multistep carcinogenesis and recently identified functions of these onco-proteins are reviewed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17645777     DOI: 10.1111/j.1349-7006.2007.00546.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  143 in total

1.  The E6 oncoprotein from HPV16 enhances the canonical Wnt/β-catenin pathway in skin epidermis in vivo.

Authors:  José Bonilla-Delgado; Gülay Bulut; Xuefeng Liu; Enoc M Cortés-Malagón; Richard Schlegel; Catalina Flores-Maldonado; Rubén G Contreras; Sang-Hyuk Chung; Paul F Lambert; Aykut Uren; Patricio Gariglio
Journal:  Mol Cancer Res       Date:  2011-12-07       Impact factor: 5.852

Review 2.  Human papillomavirus in head and neck tumors: epidemiological, molecular and clinical aspects.

Authors:  Jan Klozar; Ruth Tachezy; Eliška Rotnáglová; Eva Košlabová; Martina Saláková; Eva Hamšíková
Journal:  Wien Med Wochenschr       Date:  2010-06

3.  α,β-Unsaturated carbonyl system of chalcone-based derivatives is responsible for broad inhibition of proteasomal activity and preferential killing of human papilloma virus (HPV) positive cervical cancer cells.

Authors:  Martina Bazzaro; Ravi K Anchoori; Mohana Krishna R Mudiam; Olga Issaenko; Srinivas Kumar; Balasubramanyam Karanam; Zhenhua Lin; Rachel Isaksson Vogel; Riccardo Gavioli; Federica Destro; Valeria Ferretti; Richard B S Roden; Saeed R Khan
Journal:  J Med Chem       Date:  2010-12-27       Impact factor: 7.446

4.  KSHV co-infection regulates HPV16+ cervical cancer cells pathogenesis in vitro and in vivo.

Authors:  Lu Dai; Jing Qiao; Luis Del Valle; Zhiqiang Qin
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

Review 5.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

Review 6.  The DNA-damage response in human biology and disease.

Authors:  Stephen P Jackson; Jiri Bartek
Journal:  Nature       Date:  2009-10-22       Impact factor: 49.962

7.  Nordihydroguaiaretic acid inhibits growth of cervical cancer SiHa cells by up-regulating p21.

Authors:  Peng Gao; Fei Zhai; Lei Guan; Jie Zheng
Journal:  Oncol Lett       Date:  2010-11-10       Impact factor: 2.967

Review 8.  De vuelta a la clínica: sin justificación no existe pregunta de investigación que valga.

Authors:  Juan O Talavera; Rodolfo Rivas-Ruiz; Marcela Pérez-Rodríguez; Ivonne Analí Roy-Garcia; Lino Palacios-Cruz
Journal:  Gac Med Mex       Date:  2019       Impact factor: 0.302

9.  Detection of HPV and the role of p16INK4A overexpression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer.

Authors:  Vanessa Deschoolmeester; Veerle Van Marck; Marc Baay; Christine Weyn; Peter Vermeulen; Eric Van Marck; Filip Lardon; Veronique Fontaine; Jan B Vermorken
Journal:  BMC Cancer       Date:  2010-03-26       Impact factor: 4.430

Review 10.  Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses.

Authors:  Zhi-Ming Zheng
Journal:  Int J Biol Sci       Date:  2010-12-01       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.